Whether your company is marketing science or marketing to scientists, Kelly can help unlock insights that demonstrate thought leadership and ultimately drive conversions. She’ll interview your in-house team and craft stories that help your targeted audience understand the value of your product or service.
HOCl is a powerful yet naturally existing disinfectant that consists of three atoms: hydrogen, oxygen, and chlorine. Known for 150 years, it is like bleach’s much gentler cousin.
Read the story on Berkshire’s website.
“If you follow IT best practices from Day One, your intellectual property will be protected, and your team will only be limited by science, not technology.”
Read the white paper: iuvo Technologies.
Your water lab likely has a business goal of achieving high customer satisfaction. This is a tricky key performance indicator to measure. When you collect the results from your lab's first customer survey, you will have a benchmark for customer satisfaction.
Read it on IDEXX’s website.
Why can some people tolerate medicine while others break out in hives or sometimes even have a severe reaction called anaphylaxis? A recent genetics study found links suggesting that some people could be predisposed to medication allergies.
Read it on Northrop Grumman’s website.
“This emerging life sciences sector is helping scientists gain a deeper understanding of molecular biology. Proteins are large, complex molecules present in all living organisms. They’re created from DNA instructions and have a wide range of functions in cells…”
Read the whole story: Biospring.
Adaptation to the changing landscape of cyberthreats is paramount to the security of sensitive data and intellectual property. Especially for the life sciences industry, protecting data is paramount.
Read the white paper at RevvitySignals.com.
“You carefully wash your hands, get dressed in head-to-toe sterilized garments, and then cautiously enter the cleanroom. Despite your best efforts, the simple fact that you are human means your presence contaminates the cleanroom.”
Read the blog post: Berkshire.
Despite the inherent manufacturing complexities, researchers and investors are hopeful that the clinical benefits of novel biologics and C> will outweigh the challenges of producing them, which will eventually lead to more commercially-available advanced biologics.
Read it on the life science investor’s website.
In addition to creating written content, Kelly also moderates webinars. Check out a few of the webinars she recently moderated: